April 11, 2022
SEATTLE – Multiple sclerosis (MS), sometimes thought of as primarily affecting Whites, is also common among Hispanic and Black people. These populations often have more severe disease, likely driven […]
April 11, 2022
The study covered in this summary was published on MedRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways White matter aberration appears […]
April 11, 2022
An experimental drug that combines fixed doses of extended-release (ER) formulations of existing medications can significantly reduce symptoms in patients with untreated early-stage Parkinson’s disease (PD), […]
April 11, 2022
This article was originally published in German on Medscape. Shift work is associated with poor working memory and slower mental processing speed. This is the outcome […]
April 8, 2022
SEATTLE — A novel therapy for ataxia telangiectasia that delivers dexamethasone sodium phosphate (DSP) through autologous red blood cells has shown promise in a phase 3 clinical trial. […]
April 8, 2022
A test that measures kappa immunoglobulin free light chains in cerebrospinal fluid (KCSF) is a valid option for diagnosing multiple sclerosis (MS), new research suggests. Results […]
April 8, 2022
Statins may protect against age-related parkinsonism, new research suggests. The observational study showed older adults taking statins had a lower risk for parkinsonism than their counterparts […]
April 8, 2022
In a final decision on the funding of the controversial Alzheimer’s drug aducanumab (Aduhelm), federal officials largely stuck to their draft plan to limit Medicare payment […]
April 7, 2022
The study covered in this summary was published on MedRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways MRI provides an important […]